. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "89"^^ . . . . . "50"^^ . . . . . . . . . . . . . . . . . . . "Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients"@en . . . . "NCT00667810" . . . "Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients"@en . "Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients"@en . . . "901"^^ . . . . . . . . . . . . . . . . . . . . . . . . . "2012-10-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . "2008-06-01T00:00:00Z"^^ . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . . . "clinical trial"@en . . . . . . . . . . . . . . . "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy And Safety Trial Of Bapineuzumab (Aab-001, Eln115727) In Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Non-carriers"@en . . . "klinisch onderzoek"@nl . .